Cargando…
The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
BACKGROUND: Toll-like receptors (TLRs) play an important role in the innate and adaptive immune responses to pathogens, and are the target of new vaccine adjuvants. TLR2 plays a role in parasite recognition and activation of immune responses during cutaneous leishmaniasis infection, suggesting that...
Autores principales: | Halliday, Alice, Turner, Joseph D., Guimarães, Ana, Bates, Paul A., Taylor, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761161/ https://www.ncbi.nlm.nih.gov/pubmed/26897363 http://dx.doi.org/10.1186/s13071-016-1381-0 |
Ejemplares similares
-
An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018) -
Answer: Microfilaria of Brugia malayi
por: Khurana, Vishal, et al.
Publicado: (2014) -
Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of
Leishmanization in Mice
por: Huang, Lu, et al.
Publicado: (2015) -
Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam(1)CSK(4) and Pam(3)CSK(4)
por: Megy, Simon, et al.
Publicado: (2020) -
CRISPR-mediated Transfection of Brugia malayi
por: Liu, Canhui, et al.
Publicado: (2020)